Following its listing on the bourses on Tuesday, Sagility India's shares jumped 9.6% to an intraday high of Rs 32.90 on the BSE. At Rs 31.06, the stock's debut price on the BSE was 3.5% higher than its upper price range of Rs 30.

The NSE also saw the stock open at the same price.

Shares of Sagility India opened marginally higher than the market forecast of just Rs 0.3 each.

The IPO had a moderate subscription of 3.2 times, and the company made a respectable start on the stock market. Given the company's particular focus on the US healthcare sector, which is influenced by a number of economic and regulatory issues, the IPO performance is regarded as favorable.

"Investors ought to exercise caution. Risks could come from the company's reliance on a single market and the possible effects of changes in US policy. Furthermore, the IPO's whole offer for sale (OFS) structure and high valuation may restrict upside potential," according to Shivani Nyati, Head of Wealth at Swastika Investmart.

Nytai advises IPO participants to think about holding onto their shares by maintaining a stop loss of about Rs 28. It's also critical to keep a close eye on the market's dynamics and the company's success.

With no new issue component, the Rs 2,106 crore IPO was solely an offer-for-sale of 70.22 crore shares by the promoter, Sagility B.V. The selling shareholder will receive all proceeds, less fees.

At approximately 11 a.m. on Tuesday, Sagility India's stock was up 1.6% at Rs 31.55 on the BSE.